Overview
Genetic hypopigmentation of the skin is a broad clinical category (Orphanet code 183469) that encompasses a group of inherited disorders characterized by reduced melanin pigmentation of the skin. These conditions result from genetic defects affecting melanocyte development, melanin biosynthesis, melanosome formation, or melanin transfer to keratinocytes. The degree and distribution of hypopigmentation can vary widely, ranging from localized patches of lighter skin to generalized reduction in skin, hair, and eye pigmentation. Conditions grouped under this umbrella include, but are not limited to, various forms of oculocutaneous albinism, piebaldism, and other genetic disorders featuring skin lightening as a prominent feature. The skin is the primary organ system affected, though depending on the specific underlying condition, the eyes and hair may also be involved. Key clinical features include patches or widespread areas of lighter-than-expected skin color, which may be present from birth or develop in early childhood. Some subtypes are associated with increased susceptibility to sunburn and elevated risk of skin cancers due to reduced photoprotection from melanin. Certain syndromic forms may also involve neurological, immunological, or hematological abnormalities. There is currently no curative treatment for genetic hypopigmentation of the skin. Management is primarily supportive and preventive, focusing on rigorous sun protection (broad-spectrum sunscreen, protective clothing, avoidance of excessive UV exposure), regular dermatological surveillance for skin cancers, and ophthalmological care when ocular involvement is present. Cosmetic camouflage products may be used to address psychosocial concerns. Genetic counseling is recommended for affected individuals and their families to clarify the specific diagnosis, inheritance pattern, and recurrence risk.
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
2 eventsAswan University
Fondation Ophtalmologique Adolphe de Rothschild
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Genetic hypopigmentation of the skin.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Genetic hypopigmentation of the skin at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Rare Disease Specialist
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Genetic hypopigmentation of the skin.
Community
No community posts yet. Be the first to share your experience with Genetic hypopigmentation of the skin.
Start the conversation →Latest news about Genetic hypopigmentation of the skin
Disease timeline:
New recruiting trial: Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome
A new clinical trial is recruiting patients for Genetic hypopigmentation of the skin
New recruiting trial: Functional Impairment in Albinism
A new clinical trial is recruiting patients for Genetic hypopigmentation of the skin
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Genetic hypopigmentation of the skin
What is Genetic hypopigmentation of the skin?
Genetic hypopigmentation of the skin is a broad clinical category (Orphanet code 183469) that encompasses a group of inherited disorders characterized by reduced melanin pigmentation of the skin. These conditions result from genetic defects affecting melanocyte development, melanin biosynthesis, melanosome formation, or melanin transfer to keratinocytes. The degree and distribution of hypopigmentation can vary widely, ranging from localized patches of lighter skin to generalized reduction in skin, hair, and eye pigmentation. Conditions grouped under this umbrella include, but are not limited t
Which specialists treat Genetic hypopigmentation of the skin?
23 specialists and care centers treating Genetic hypopigmentation of the skin are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.